Cassandra....your estimation is close to 9 Billion doses.....IF a company is vertically integrated..then one can expect prices to be lower......essentially seed to sale is a winning combination All the time.......the caveat will always be..how efficacious are the doses ....especially within the landscape of Variants/Mutations on the rise. VACCINES seem to be in the area of ..design....supply.....distribution....not unlike Vyrologix...the Exceptional difference is we are not having to deal with the possible changes in the landscape. as we currently know it to be......We know the attack strategy...stop it from Advancing further and mitigate existing damage........IF.... as we believe it is capable of this Singular advantage...$$$$$ will flow like water to us from those that wish to get BACK to some sense of Normalcy........I believe the government will represent a Lion's share of that investment....whether it comes from the newly named OWS or some newly devised appropriations committee is yet to be seen.....efficacy first..infusion second..